Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan

NCT01758380 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

557

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Vildagliptin
DRUG: Gliclazide
DRUG: Metformin
DRUG: Placebo to Gliclazide
DRUG: Placebo to Vildagliptin

Sponsor

Novartis Pharmaceuticals